Insights On Quality Control
-
Digitizing Quality Management: The Key To Avoiding FDA Recalls In Life Sciences
1/13/2025
Explore the need for digital quality management systems to ensure compliance as life science companies face rising FDA recalls.
-
From Day One Success To Everyday Improvement: The OR → OE Continuum
11/24/2025
Bridging the gap between initial startup and long-term sustainability requires a unified strategy. Learn to transform early readiness metrics into a durable operating system that drives continuous performance improvements.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics
9/13/2024
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
-
Human Performance In Pharma: Strengthening The Biotech Workforce
11/24/2025
Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.
-
Pave The Way To High Productivity With Continuous Manufacturing For Pharma
12/12/2025
Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.
-
Regulatory Compliance And Advanced Solutions For Aseptic Environmental Monitoring
1/29/2026
Modern aseptic monitoring requires a shift from periodic checks to risk-based strategies. Learn how to integrate particle and environmental data to meet Annex 1 standards and ensure patient safety.
-
ICH Q9 Revision 1: Enhancing Quality Risk Management
8/12/2024
ICH Q9 Revision 1 advances the framework of Quality Risk Management (QRM) in the pharmaceutical industry, by addressing technological advancements and evolving regulatory expectations.
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance
2/24/2026
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
-
A CDMO's Take On Psychedelic Formulation
1/26/2026
Psychedelics show therapeutic promise, but face major formulation and regulatory hurdles. Advances in delivery and neuroscience may unlock new mental‑health treatments.
-
Mitigating Risks In Sterile Injectable Manufacturing: How CMOs Can Ensure Product Safety
7/23/2025
Sterile injectable manufacturing carries high risks. CMOs like Afton Scientific use rigorous quality systems, audits, and training to ensure patient safety, compliance, and product integrity.